Juan Carlos Rivera-Mulia, PhD, in the Department of Biochemistry, Molecular Biology and Biophysics, helped to expand the catalogue of functional elements in the human genome to nearly one million as part of an NIH-funded ENCODE Project.
Paulo Kofuji, PhD, and Alfonso Araque, PhD, both in the Department of Neuroscience, recently received a five-year, $2.2 million grant from the National Institute of Mental Health to study how manipulation of astrocytes – glial cells in the brain – in the brain’s amygdala regulate fear.
Katie Loth, PhD, MPH, RD, in the Department of Family Medicine and Community Health, is leading a study to identify ways that public health practitioners and policymakers can support vulnerable Minnesota families.
Dr. Mustafa al'Absi, an expert in behavioral health, joins WCCO Radio to talk about managing stress during the COVID-19 pandemic.
Associate Professor, Dr. Raymond Christensen kicked off the 39th season of PBS North’s ‘Doctors on Call,’ focusing on COVID-19 Updates with a panel of experts.
Jesse Williams, PhD, in the Department of Integrative Biology and Physiology, published his team’s study in “Nature Immunology,” which defines the role of a tissue resident macrophage population in the initiation of atherosclerotic lesions within the artery and identifies new gene programs associated with their function in homeostasis and disease.
Mustafa al’Absi, PhD, in the Department of Family Medicine and Biobehavioral Health, talks about ways to recognize and reduce stress during the COVID-19 pandemic and beyond.
Anna Wirta Kosobuski, EdD, in the Department of Biomedical Sciences on the Duluth campus, received a COVID-19 grant to identify elements for effective, culturally-grounded therapy models for Native American youth.
A significant grant from METAvivor worth $500,000 over three years will allow Carol Lange, PhD, a professor in the Department of Medicine and Pharmacology, to analyze the biological mechanisms behind breast cancer, particularly how steroid hormone receptors impact the disease.
Researchers are developing antibody-based medical countermeasures against overdose of fentanyl, fentanyl-like drugs.